secwatch / observer
8-K filed Feb 13, 2025 23:59 UTC ticker CLSDQ CIK 0001539029
regulatory confidence high sentiment negative materiality 0.70

Clearside Biomedical receives Nasdaq minimum bid price deficiency notice

Clearside Biomedical, Inc.

Machine-readable event card

schema_version
secwatch.filing_event.v1
accession
0000950170-25-019866
form_type
8-K
ticker
CLSDQ
cik
0001539029
company_name
Clearside Biomedical, Inc.
filed_at
2025-02-13T23:59:59+00:00
discovered_at
2026-05-14T18:03:03.947762+00:00
generated_at
2026-05-26T22:14:58.270709+00:00
sec_items
["3.01"]
event_type
regulatory
sentiment
negative
materiality_score
0.7
confidence
high
secwatch_canonical_url
https://secwatch.observer/filing/0000950170-25-019866
json_url
https://secwatch.observer/filing/0000950170-25-019866.json
markdown_url
https://secwatch.observer/filing/0000950170-25-019866.md
text_url
https://secwatch.observer/filing/0000950170-25-019866.txt
edgar_index_url
https://www.sec.gov/Archives/edgar/data/1539029/000095017025019866/0000950170-25-019866-index.htm
edgar_primary_document_url
https://www.sec.gov/Archives/edgar/data/1539029/000095017025019866/clsd-20250207.htm
generated_by_model
deepseek-v4-flash:cloud@v2
review_status
machine_generated
human_reviewed
false
corrected
false
correction_note
null
correction_timestamp
null
superseded_by
null

Source-grounded claims

a82228f1716d8d6b356192a8345b0975aab07d85

Clearside Biomedical, Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5450(a)(1)).

February 7, 2025, Clearside Biomedical, Inc. (the “ Company ”) received a notice from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“ Nasdaq ”) notifying the Company that the listing of its common

SEC 8-K Item 3.01 confidence 0.9 SEC evidence

Source: SEC EDGAR
accession 0000950170-25-019866

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.